Losartan Potassium and Hydrochlorothiazide Tablets — Class II drug recall D-0498-2024
Ongoing recall by MACLEODS PHARMA USA, INC, reported 2024-05-22, distributed nationwide. Presence of foreign substance: plastic-like substance.
| Recall number | D-0498-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | MACLEODS PHARMA USA, INC, Princeton, NJ, United States |
| Recall initiated | 2024-05-07 |
| Classified | 2024-05-15 |
| Reported by FDA | 2024-05-22 |
| Distributed | Nationwide (US) |
| Quantity | 1,048 bottles |
| NDC | 33342-0050, 33342-0050-07, 33342-0050-10, 33342-0050-12, 33342-0050-44, 33342-0051, 33342-0051-07, 33342-0051-10, 33342-0051-12, 33342-0051-44, 33342-0052, 33342-0052-07, 33342-0052-10, 33342-0052-12, 33342-0052-44 |
| Lot numbers | BLK2304A |
| Expiration dates | 2025-07-31 |
Product
Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44
Reason for recall
Presence of foreign substance: plastic-like substance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0498-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.